Exact enlists Pfizer to boost Cologuard sales

Exact Sciences Corp. (NASDAQ:EXAS) gained $15.27 (31%) to $65.32 on Wednesday after partnering with Pfizer Inc. (NYSE:PFE)

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE